Statistics
1 - 15 of
23 Results
Sort Results:
Commentary:
Applying Study Results to Patient Care: Relative Risk, Absolute Risk, and Number Needed to Treat
October 2017
Article:
The Avandia (rosiglitazone) debate will heat up again now that FDA will loosen its restrictions
January 2014